BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37598464)

  • 1. In-depth analysis of immunohistochemistry concordance in biopsy-resection pairs of bronchial carcinoids.
    Naves DD; Reuling EMBP; Dickhoff C; Kortman PC; Broeckaert MAM; Plaisier PW; Daniels JMA; Thunnissen E; Radonic T
    Ann Diagn Pathol; 2023 Dec; 67():152181. PubMed ID: 37598464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of atypical carcinoid can be made on biopsies > 4 mm
    Reuling EMBP; Naves DD; Daniels JMA; Dickhoff C; Kortman PC; Broeckaert MAMB; Plaisier PW; Thunnissen E; Radonic T
    Virchows Arch; 2022 Mar; 480(3):587-593. PubMed ID: 35089404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
    Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
    Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoid tumors of the lung and multimodal therapy.
    Divisi D; Crisci R
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):168-72. PubMed ID: 15926097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
    Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptophysin Positive Glomus Tumor of Trachea Simulating Typical Carcinoid: A Potential trap.
    Kamboj M; Durga G; Pasricha S; Darlong LM; Jajodia A; Gupta G; Sharma A; Koyyala VPB; Mehta A
    Head Neck Pathol; 2021 Sep; 15(3):994-998. PubMed ID: 33025460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
    Gosney JR; Gosney MA; Lye M; Butt SA
    Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial carcinoid tumors: a prospective study].
    Pareja E; Arnau A; Artigues E; Peiró F; Hostalet F; Martín E; Cantó A
    Arch Bronconeumol; 1998 Feb; 34(2):71-5. PubMed ID: 9557178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.